has abbvie by as declined has by by increased in by on with
with of were by
is as sold while
has since is uptrending
has of in
stated has of in
ltd has in
of has on by
maintained of in on with
among covering hold
of has on by
also reduced in by in leaving with cut in
manages about upped in nasdaq by at in according
